Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
B.1.151ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-24645.6Germany
B.1.151ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
B.1.151EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
B.1.151EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
B.1.151ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.151ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.36.2EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.36.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.36.2ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-24645.6Germany
B.1.36.2ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
B.1.36.2EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
B.1.36.2EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
B.1.36.2ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.36.2ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.177.10EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.177.10EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.177.10ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-24645.6Germany
B.1.177.10ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
B.1.177.10EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
B.1.177.10EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
B.1.177.10ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.177.10ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.177.17EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.177.17EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.177.17ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-24645.6Germany
B.1.177.17ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
B.1.177.17EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
B.1.177.17EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
B.1.177.17ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.177.17ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.164EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.1.164EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.164ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-24645.6Germany
B.1.1.164ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
B.1.1.164EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
B.1.1.164EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
B.1.1.164ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.1.164ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.275EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.1.275EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.275ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-24645.6Germany
B.1.1.275ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
B.1.1.275EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
B.1.1.275EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
B.1.1.275ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.1.275ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.258.2EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.258.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.258.2ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-24645.6Germany
B.1.258.2ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used